Skip to content

Clinical and resting brain functional imaging study of acupuncture treating atopic dermatitis from the heart

Clinical and resting brain functional imaging study of acupuncture treating atopic dermatitis from the heart

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2022000076
Enrollment
Unknown
Registered
2022-08-08
Start date
2022-10-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atopic dermatitis

Interventions

sham acupuncture group:sham acupuncture
acupuncture group:acupuncture

Sponsors

Guang'anmen hospital, China Academy of Chinese medicine sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Age: 18-60 years old, gender is not limited. 2. According to Williams criteria, the diagnosis of AD was met: main criteria: skin itching. Secondary criteria: ? history of flexor involvement, including popliteal fossa, cubital fossa, anterior ankle and neck; ? History of asthma or allergic rhinitis; ? History of systemic skin dryness in recent years; ? There was flexor eczema; ? Onset before 2 years old. Ad can be diagnosed when the patient meets the main criteria and meets 3 or more secondary criteria. 3. No serious heart, cerebrovascular, liver, kidney, endocrine system, hematopoietic system, mental and other serious diseases. 4. No corticosteroids, non steroidal anti-inflammatory drugs and immunosuppressive drugs were used within 1 month. 5. No previous history of autoimmune diseases. 6. Volunteer and agree to complete all steps of this clinical study.

Exclusion criteria

Exclusion criteria: 1. Women with reproductive needs, pregnancy and lactation during the study period. 2. Contraindications of magnetic resonance. 3. Participating in or participating in other clinical trials within the last 3 months. 4. Left handedness. 5. Have taken psychotropic drugs within 1 month.

Design outcomes

Primary

MeasureTime frame
SCORAD;

Countries

China

Contacts

Public ContactWang Yu-ming

Guang'anmen hospital, China Academy of Chinese medicine sciences,

wangyumingmmm@163.com01088001332

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026